Sign in to view content

Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process

Raj K. Maturi, MD

Video
Published 2019

Related

Improvement of Worsening in Diabetic Retinopathy Through 2 Years in a Randomized Trial
Susan B. Bressler, MD, FASRS
Updates from the Field
2017
Single Intraoperative Subconjunctival Triamcinolone Acetonide Injection Versus 4-6-Week Topical Steroid Taper Following Vitreore
Elizabeth A Atchison, MD
Updates from the Field
2018
What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study
Roger A. Goldberg, MD, MBA
Updates from the Field
2019

Category: AMD-Neovascular

See more